Jump to content

Oticon

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by GreenC bot (talk | contribs) at 06:09, 3 April 2023 (Rescued 1 archive link. Wayback Medic 2.5). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Oticon
Founded1904
FounderHans Demant
Headquarters
Smørum, Egedal
,
Denmark
ProductsHearing aids
Number of employees
3000+
ParentWilliam Demant Holding Group

Oticon is a hearing aid manufacturer based in Copenhagen, Denmark. The company is a subsidiary of the Demant Group. It was founded in 1904 by Hans Demant, whose wife was hearing impaired. The company claims to be the world's second-largest manufacturer of hearing aids, and uses a management style known as "spaghetti organization"[1][2] introduced by Lars Kolind[3][4][5] under his leadership between 1988 and 1998.[6][7][8]

Oticon has branches in several countries, including a production plant in Poland, with more than 3,000 employees worldwide.[9]

Oticon hearing aid

In 2016, Oticon launched what they claim to be the world's first internet-connected hearing aid, called the Oticon Opn. The company employs an "open sound" approach designed to manage multiple speech and noise sources, even in complex listening situations. The company says the new OpenSound Navigator scans the environment 100 times per second to analyze and balance every sound individually. Environmental sounds are said to be accessible, but not disturbing.[10]

Oticon Medical

Oticon Medical is a sister company of Oticon, both being subsidiaries of the Demant Group.[11] Whereas Oticon specialises in hearing aids, Oticon Medical specialises in hearing implants and released its first products in 2009.[12] The company's Ponto bone conduction implant is now in its fifth generation.[13]

In 2013, Oticon Medical acquired Neurelec, a French producer of cochlear implants.[14] Using the acquired technology, the company developed its own Neuro cochlear implant system, which received FDA approval in 2021.[15]

In April 2022, Demant announced it had agreed to sell Oticon Medical to Australian company Cochlear Limited for DKK850 million and would exit the hearing implant business.[16]

References

  1. ^ "Oticon A/S: Spaghetti Organization and Beyond". IBS Center for Management Research. Retrieved 12 September 2012.
  2. ^ "Case Study: Revolution at Oticon A/S: The Spaghetti Organization (Condensed)". Harvard Business Review. Retrieved 10 September 2012.
  3. ^ Peters, Tom (January 1994). Liberation Management. United States: Ballantine Books. p. 880. ISBN 0-449-90888-7.
  4. ^ Ewing, Jack (6 August 2007). "Denmark's Masters of E-Mail Marketing". Bloomberg Businessweek. Archived from the original on 9 July 2012. Retrieved 12 September 2012.
  5. ^ Poulsen, Per Thygesen (1993). Tænk det utænkelige: Revolutionen i Oticon. Denmark: Schultz Erhvervsbøger. p. 174. ISBN 87-569-7920-7.
  6. ^ Tænk det utænkelige: Revolutionen i Oticon. 1993. ISBN 9788756979207. Retrieved 12 September 2012.
  7. ^ "Think the Unthinkable (in Danish: Tænk det utænkelige!)". Kolind Kuren. Retrieved 12 September 2012.
  8. ^ Morsing, Mette; Eiberg, Kristian (1998). Managing the Unmanageable for a Decade. Denmark: Oticon A/S. p. 244.
  9. ^ "Oticon Hearing Aids". Apex Hearing. Retrieved 6 May 2014.
  10. ^ Nuber, Christa. "Oticon's New Hearing Aid Takes 'Open Sound' Approach". www.hearingreview.com.
  11. ^ "Oticon Medical – A company founded on care". earcommunity.org. Retrieved 24 March 2022.
  12. ^ "Our history". www.demant.com. Retrieved 24 March 2022.
  13. ^ "Oticon Medical bone-anchored hearing devices". Healthy Hearing. Retrieved 24 March 2022.
  14. ^ Apr 2; Ear, 2013 | Behind the; Implants, Cochlear; News | 0 |, Industry (2 April 2013). "William Demant Acquires Neurelec, a French Manufacturer of Cochlear Implants". The Hearing Review. Retrieved 24 March 2022.{{cite web}}: CS1 maint: numeric names: authors list (link)
  15. ^ "FDA approves Oticon Medical's Neuro cochlear implant system". MassDevice. 24 June 2021. Retrieved 24 March 2022.
  16. ^ Ogg, Matt (27 April 2022). "Cochlear to acquire loss-making Oticon Medical for $170 million". Business News Australia. Retrieved 6 May 2022.